Longboard Pharmaceuticals, Inc. (LBPH) Financials
Stock symbol LBPH is outdated, potentially delisted? Maybe it is available on other exchange?
LBPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 58.9 million | 6.8 million |
| June 30, 2023 | 66.2 million | 8.1 million |
| March 31, 2023 | 79.7 million | 7.6 million |
| Dec. 31, 2022 | 70.6 million | 9.1 million |
LBPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -13.3 million | 856000 |
| June 30, 2023 | -13.5 million | 841000 |
| March 31, 2023 | -13.1 million | 697000 |
| Dec. 31, 2022 | -9.7 million | 592000 |
LBPH Net Income
No data available :(
LBPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 56.0 million | - | 502000 |
| June 30, 2023 | 63.0 million | - | 589000 |
| March 31, 2023 | 76.1 million | - | 683000 |
| Dec. 31, 2022 | 67.6 million | - | 740000 |
LBPH Shares Outstanding
LBPH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 10.5 million | 3.1 million | - |
| June 30, 2023 | - | 12.5 million | 3.1 million | - |
| March 31, 2023 | - | 8.5 million | 3.4 million | - |
| Dec. 31, 2022 | - | 9.2 million | 2.5 million | - |
LBPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 1000 |
| June 30, 2023 | - | 2000 |
| March 31, 2023 | - | 1000 |
| Dec. 31, 2022 | - | 1000 |
LBPH
Price: $59.98
52 week price:
Earnings Per Share: -2.25 USD
P/E Ratio: -8.09
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65700
Market Capitalization: 2.3 billion